98%
921
2 minutes
20
Background: Since miRNAs can play important roles in different cancer types, how to discover cancer related miRNAs is an important issue. In general, the miRNAs with differential expression is the focus of attention. However, some important cancer related miRNAs are not excavated by differential expression analysis. We take this type of miRNAs as 'dark matters' (DM-miRNA). It is our great interests to develop an algorithm to discover DM-miRNAs.
Results: An effective method was developed to find DM-miRNAs. This method is mainly for mining potential DM-miRNAs by building basic miRNA-mRNA network (BMMN) and miRNA-lncRNA network (BMLN). The results indicate that miRNA-mRNA and miRNA-lncRNA interactions can be used as novel cancer biomarkers.
Conclusions: The BMMN and BMLN can excavate the non-differentially expressed miRNAs which play an important role in the cancer. What's more, the edge biomarkers (miRNA-mRNA and miRNA-lncRNA interactions) contain more information than the node biomarkers. It will contribute to developing novel therapeutic candidates in cancers.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192342 | PMC |
http://dx.doi.org/10.1186/s12859-018-2410-0 | DOI Listing |
Clin Cosmet Investig Dermatol
August 2025
Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Hospital of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, 210042, People's Republic of China.
Background: Vitiligo is an acquired depigmentary disorder caused by the loss of functional melanocytes. Increasing evidence suggests that competing endogenous RNA (ceRNA) interactions participate in this process, yet their global architecture in vitiligo remains unclear.
Objective: To delineate a long non-coding RNA (lncRNA)-microRNA (miRNA)-mRNA ceRNA network associated with vitiligo and to identify blood-borne RNA markers with diagnostic potential.
Int J Mol Sci
August 2025
State Key Laboratory of Mariculture Biobreeding and Sustainable Goods, Heilongjiang River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Harbin 150070, China.
High-throughput transcriptomic analyses have identified numerous candidate miRNA-mRNA and long non-coding RNA (lncRNA) regulatory networks in teleosts, but most remain without systematic functional validation or mechanistic definition. Here, by interrogating miRNA-lncRNA networks in rainbow trout () gonads, we define their roles in meiotic progression and gonadal development. From preliminary screening, we identified as a central node and characterised its function.
View Article and Find Full Text PDFClin Exp Med
July 2025
Department of Medical Genetics, Faculty of Medicine, School of Medical Sciences, Hormozgan University of Medical Sciences, P.O.Box: 7919693116, Bandar Abbas, Iran.
Objectives: This study aims to elucidate the complex molecular and cellular landscape of pancreatic ductal adenocarcinoma (PDAC) by identifying key regulatory non-coding RNAs (ncRNAs), hub protein-coding genes, and Intercellular communication pathways that may serve as prognostic biomarkers and therapeutic targets.
Background: Pancreatic cancer remains one of the deadliest malignancies worldwide, characterized by late diagnosis, limited treatment response, and poor prognosis. Among its histological subtypes, PDAC accounts for over 80% of cases and is defined by a highly fibrotic and immunosuppressive tumor microenvironment (TME).
Front Neurol
June 2025
Department of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Background: Myocardial injury is a common complication of aneurysmal subarachnoid hemorrhage (aSAH) and is associated with poor outcomes. While RNA plays a critical role in pathophysiological processes, its expression patterns and functions in myocardial injury after aSAH (aSAH-MI) remain poorly understood.
Objective: To construct the RNA expression profile of aSAH-MI patients, explore their biological functions, and establish a gene expression regulatory network for aSAH-MI.
Clin Exp Med
May 2025
Department of Medical Genetics, Faculty of Medicine, School of Medical Sciences, Hormozgan University of Medical Sciences, P.O. Box 7919693116, Bandar Abbas, Iran.
This study aims to dissect the complex molecular landscape of glioblastoma multiforme (GBM), focusing on identifying key regulatory non-coding RNAs and protein-coding genes that could serve as therapeutic targets and prognostic biomarkers. GBM is an aggressive form of brain cancer characterized by poor prognosis and limited treatment options. Recent advances in high-throughput genomic technologies have opened new avenues for understanding the molecular underpinnings of GBM, with a particular focus on the roles of ncRNAs.
View Article and Find Full Text PDF